Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin/Paclitaxel vs Carboplatin/Gemcitabine in Recurrent Ovarian Cancer
NCT01570582Phase 2Unknown
- Sponsor
- Korean Gynecologic Oncology Group
- Start
- Mar 2010
- Primary completion
- Mar 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel, gemcitabine in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Korean Gynecologic Oncology Group. Status: unknown.
02
Drugs
carboplatinpaclitaxelgemcitabine
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01570582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01570582.